Chronic conditions are among the most common causes of death and disability in the United States. Patients with such conditions receive disproportionate amounts of health care services and therefore cost more per capita than the average patient. This study assesses the prevalence among the Department of Veterans Affairs (VA) health care users and VA expenditures (costs) of 29 common chronic conditions. The authors used regression to identify the marginal impact of these conditions on total, inpatient, outpatient, and pharmacy costs. Excluding costs of contracted medical services at non-VA facilities, total VA health care expenditures in fiscal year 1999 (FY1999) were $14.3 billion. Among the 3.4 million VA patients in FY1999, 72 percent had 1 or more of the 29 chronic conditions, and these patients accounted for 96 percent of the total costs ($13.7 billion). In addition, 35 percent (1.2 million) of VA health care users had 3 or more of the 29 chronic conditions. These individuals accounted for 73 percent of the total cost. Overall, VA health care users have more chronic diseases than the general population.
Agency for Healthcare Research and Quality. 2000. Clinical classifications software, fact sheet. Available from http://www.ahrq.gov/data/hcup/cccsfact.htm
2.
American Dental Association. 2000. American Dental Association 1999 survey of dental fees. Chicago: Author.
3.
American Diabetes Association. 1998. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care21 (2): 296-309.
4.
Amin, S. P., C. D. Mullins, B. S. Duncan, and L. Blandford. 1999. Direct healthcare costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO. American Journal of Health-System Pharmacy56 (15): 1515-1520.
5.
Ash, A. S., R. P. Ellis, G. C. Pope, J. Z. Ayanian, D. W. Bates, H. Burstin, L. I. Iezzoni, E. MacKay, and W. Yu. 2000. Using diagnoses to describe populations and predict costs. Health Care Financial Review21 (3): 7-28.
6.
Barnett, V., and T. Lewis. 1994. Outliers in statistical data. Chichester, UK: John Wiley.
7.
Demakis, J. G., L. McQueen, K. W. Kizer, and J. R. Feussner. 2000. Quality Enhancement Research Initiative (QUERI): A collaboration between research and clinical practice. Medical Care38 (6): 17-25.
8.
Deyo, R. A., D. C. Cherkin, and M. A. Ciol. 1992. Adapting a clinical comorbidity index for use withICD-9-CM administrative databases. Journal of Clinical Epidemiology45 (6):613-619.
9.
Duan, N.1983. Smearing estimate: A nonparametric retransformation method. Journal of the American Statistical Association78 (383): 605-610.
10.
Fishman, P., M. Von Korff, P. Lozano, and J. Hecht. 1997. Chronic care costs in managed care. Health Affairs (Project Hope)16 (3): 239-247.
11.
Friedman, M., and D. E. Hilleman. 2001. Economic burden of chronic obstructive pulmonary disease: Impact of new treatment options. Pharmacoeconomics19 (3): 245-254.
12.
Garber, A. M., T. E. MaCurdy, and M. L. McClellan. 1998. Medical care at the end of life: Diseases, treatment patterns and costs. In Frontiers in health policy research, edited by A. M. Garber. Cambridge, MA: MIT Press.
13.
Gilmer, T. P., P. J. O'Connor, W. G. Manning, and W. A. Rush. 1997. The cost to health plans of poor glycemic control. Diabetes Care20 (12): 1847-1853.
14.
Guico-Pabia, C. J., J. F. Murray, S. M. Teutsch, A. I. Wertheimer, and M. L. Berger. 2001. Indirect cost of ischemic heart disease to employers. American Journal of Managerial Care7 (1): 27-34.
15.
Hoffman, C., D. Rice, and H. Y. Sung. 1996. Persons with chronic conditions. Their prevalence and costs. JAMA276 (18): 1473-1479.
16.
Hsiao, W. C., P. Braun, D. L. Dunn, E. R. Becker, D. Yntema, D. K. Verrilli, E. Stamenovic, and S. P. Chen. 1992. On overview of the development and refinement of the Resource-Based Relative Value scale: The foundation for reform of U.S. physician payment. Medical Care30:1-12.
17.
Hynes, D. M., G. Joseph, and C. Pfeil. 2002. Using VistA data for research. In VIReC IN-sights. Hines, IL: VA Information Resource Center.
18.
Ingenix. 2000. St. Anthony's 2000 RBRVS: A comprehensive listing of RBRVS values for all CPT and HCPCS codes. Salt Lake City, UT: Author.
19.
Jacobs, R. P.1998. Hypertension and managed care. American Journal of Managerial Care4 (12): 749-752.
20.
Leake, A. R.1995. The economic impact of cancer. Nurse Practitioner Forum6 (4): 207-214.
21.
Leese, B.1992. The costs of diabetes and its complications. Social Science & Medicine35 (10): 1303-1310.
22.
Manning, W. G.1998. The logged dependent variable, heteroscedasticity, and the retransformation problem. Journal of Health Economics17 (3): 283-295.
23.
Manning, W. G., and J. Mullahy. 2001. Estimating log models: To transform or not to transform?Journal of Health Economics20 (4): 461-494.
24.
Mapel, D. W., J. S. Hurley, F. J. Frost, H. V. Petersen, M. A. Picchi, and D. B. Coultas. 2000. Health care utilization in chronic obstructive pulmonary disease: A case-control study in a health maintenance organization. Archives of Internal Medicine160 (17): 2653-2658.
25.
Murphy, P. A., D. C. Cowper, G. Seppala, et al.2002. Veterans Health Administration in-patient and outpatient care data: An overview. Effective Clinical Practice5 (3 Suppl.): E4.
26.
Murray, C. J., and A. D. Lopez. 1996. Evidence-based health policy—Lessons from the Global Burden of Disease Study. Science274 (5288): 740-743.
27.
Office of Research and Development. 1998. Designated research areas for an integrated program of research. Veterans Health Administration, Department of Veterans Affairs.
28.
Peterson, K. A., R. W. Swindle, C. S. Phibbs, B. Recine, and R. H. Moos. 1994. Determinants of readmission following inpatient substance abuse treatment: A national study of VA programs. Medical Care32 (6): 535-550.
29.
Phibbs, C. S., A. Bhandari, W. Yu, and P. G. Barnett. 2003. Estimating the costs of VA ambulatory care. Medical Care Research and Review, 60 (3 Suppl.): 54S-73S.
30.
Ray, G. T., F. Collin, T. Lieu, B. Fireman, C. J. Colby, C. P. Quesenberry, S. K. Van den Eeden, and J. V. Selby. 2000. The cost of health conditions in a health maintenance organization. Medical Care Research and Review57 (1): 92-109.
31.
Ruchlin, H. S., and E. J. Dasbach. 2001. An economic overview of chronic obstructive pulmonary disease. Pharmacoeconomics19 (6): 623-642.
32.
Selby, J. V., G. T. Ray, D. Zhang, and C. J. Colby. 1997. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care20 (9): 1396-1402.
33.
Shen, Y., A. M. Hendricks, S. Zhang, and L. Kazis. 2003. VHA enrollees' health care coverage and use of care. Medical Care Research and Review60 (2): 253-267.
34.
Simell, T. T., H. Sintonen, J. Hahl, and O. G. Simell. 1996. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics9 (1): 24-38.
35.
Simon, G. E., M. VonKorff, and W. Barlow. 1995. Health care costs of primary care patients with recognized depression. Archives of General Psychiatry52 (10): 850-856.
36.
Stason, W. B.1989. Cost and quality trade-offs in the treatment of hypertension. Hyper-tension13 (5): 145-148.
37.
State of California. 1999. State of California Worker's Compensation Official Medical Fee Schedule. San Francisco: Department of Industrial Relations.
38.
Strassels, S. A.1999. Economic consequences of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine5 (2): 100-104.
39.
Strassels, S. A., D. H. Smith, S. D. Sullivan, and P. S. Mahajan. 2001. The costs of treating COPD in the United States. Chest119 (2): 344-352.
40.
Strauss, M. J., D. Conrad, J. P. LoGerfo, L. D. Hudson, and M. Bergner. 1986. Cost and outcome of care for patients with chronic obstructive lung disease: Analysis by physician specialty. Medical Care24 (10): 915-924.
41.
Taplin, S. H., W. Barlow, N. Urban, M. T. Mandelson, D. J. Timlin, L. Ichikawa, and P. Nefcy. 1995. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. Journal of the National Cancer Institute87 (6): 417-426.
42.
Wagner, T. H., S. Chen, and P. G. Barnett. 2003. Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA. Medical Care Research and Review60 (3 Suppl.): 15S-36S.
43.
Wasserman, Yale. 2000. 2000 National Dental Advisory Service Comprehensive Fee Report. West Allis, WI: Medical Publishers.
44.
Weiner, M., N. R. Powe, W. E. Weller, T. J. Shaffer, and G. F. Anderson. 1998. Alzheimer's disease under managed care: Implications from Medicare utilization and expenditure patterns. Journal of the American Geriatric Society46 (6): 762-770.
45.
Wittels, E. H., J. W. Hay, and A. M. Gotto, Jr.1990. Medical costs of coronary artery disease in the United States. American Journal of Cardiology65 (7): 432-440.
46.
Wright, S. M., M. Hossain, and L. A. Petersen. 2000. Enrollment in the Medicare pro-gram among Veterans Turning age 65. Paper read at the VAHSR&D Annual Conference, 22-24 March, Washington, DC.
47.
Wright, S. M., R. P. Lamkin, and L. A. Petersen. 2000. Medicare enrollment status among VA users by VISN. Paper read at the VA HSR&D Annual Conference, 22-24 March, Washington, DC.
48.
Yu, W., T. H. Wagner, S. Chen, and P. G. Barnett. 2003. Average cost of VA rehabilitation, mental health, and long-term hospital stays. Medical Care Research and Review60 (3 Suppl.) 40S-53S.
